U.S. Markets closed

Todos Medical Ltd. (TOMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1021-0.0019 (-1.83%)
At close: 3:48PM EDT
Sign in to post a message.
  • D
    David
    For those interested in TOMDF's manipulated market-maker trade tactics:
    This morning, in the Level II, trader CDEL has been offering 100,000 shares bid at .097 cents, while simultaneously offering 188,000 shares at
    .098 cents. ~ The attempt to drive the share price, either way, while dumping shares at the optimum price is clear.
    They must be working on commission for LPC. ~ Spoof-trading is going on here as well.
    ~ Looked up CDEL. Here's what I found:
    CDEL– Citidel Securities is one of the largest market makers in the world for fixed income and options trading.
  • A
    AynRandwasright
    Unless this stock pops on huge news, and it seems there are forces determined to prevent that from happening, they are going to do a 1-20+ RS and then LP will short it down. I want to be wrong so I welcome a counter argument
  • D
    David
    The obvious attempted manipulation I see here is all this talk of a r/s on this board. Strong enough, proven growth, a few quarters of it, accelerating, and a r/s can do exactly what it was designed for a be a big positive. A r/s done in an effort to artificially raise share price without that proven underlying and substantial growth and it often ends up failing at its purpose and being a bad thing. Bottom line, all this talk of a r/s now is just guesswork, and manipulation, IMHO. After all, the company states institutional investors are telling them the share price is significantly undervalued, and should already be much higher, so they may well be thinking of driving share price higher the old fashioned way, strong fundamental growth, and news to support such. That's what I'm hoping their plan is, and there is basis to believe that is the case.
  • D
    David
    PLEASE check out this part of Gerald's letter!!!! (See below).
    I feel his implied need to get listed on NASDAQ is indication of a forthcoming R/S.
    ~But! ...Also, he reports their institutional shareholders, (LPC),agree to stop dilution for one month(???)!
    The devil's in the details.
    Go Gerald!!!!! 👍
    ☆☆☆Todos has been evaluating how best to achieve a national listing on the Nasdaq for some time. With the Company’s financial position steadily improving, we have become very focused on the mechanics to make this transition happen. We have heard from several investors that this listing would be a transformational event for the Company. As such, all of our institutional shareholders who invested between January 2019 and March 2020 believe that the Company’s common stock is sorely undervalued, and as a show of support have agreed to cease diluting the Company’s common stock for approximately one month, at no cost to the Company.
  • J
    JasonD7
    might be time to get out at my break even point................all that good news over the last month and the price is still the same, with the exception of that spike to .18 and back down........seems clear manipulation to me and or dilution............and anytime I see the letters r/s wether true or not im out. Ill just hold ambs for now i dont need both.
  • D
    David
    Another interesting PR this morning. The breadth of this little company's product offerings and research/development continues to grow. Offering such a natural supplement potentially relevant to the coronavirus and any future mutations, even as they continue to develop and pursue trials for other related and serious products, this intrigues the heck out of me. Long & Strong!
  • D
    David
    Once again: pre market Level III, a higher offer with fewer shares and a lower bid with greater number of shares FROM THE SAME TRADER.
    Got to love the obvious attempt to set the bait in order to dump shares. 🤣
  • n
    noah
    I personally want to know how much stock gerald has. It doesn’t say it anywhere besides that todo owns 49% of ambs, and can’t find how much ambs he owns either. If anyone has the answer or know where to look please let me know. I’ve checked OTCmarkets
  • J
    Jon
    Todos Medical Announces Commercial Launch of Todos Branded COVID-19 qPCR Test Kits in the United States

    https://investor.todosmedical.com/news-events/press-releases/detail/78/todos-medical-announces-commercial-launch-of-todos-branded

    NEW YORK, NY, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that the U.S. Food and Drug Administration (FDA) has added the TODOS 2019-nCoV RT-qPCR Detection Kit to its Notified List under the Emergency Use Authorization program. Todos is required to submit an Emergency Use Authorization application to the FDA within 15 days of submission of the notification.

    The Todos test is currently authorized to use only the QuantStudio 12Flex Instrument as a platform to perform the RT-PCR assay. It is estimated that there are more than 1,000 QuantStudio 12Flex Instrument installations in United States. The Company anticipates first shipments of test kits for existing CLIA laboratory clients to begin next week and will be working with those existing clients to complete validations on additional RT-PCR instruments to expand the commercial reach of the Todos test to include additional RT-PCR instruments. The Company currently has access to sufficient raw materials to manufacture approximately 1,000,000 test kits per week and is expanding its warehouse and logistics capabilities to meet an expected surge in demand in the weeks ahead given the testing market’s desire for a highly accurate and analytically stable COVID-19 qPCR test. The Todos test instructions for use (IFU) include use of Todos proprietary ANDis 350 extraction system and extraction reagents that ensure consistency in the RNA extraction and purification process prior to RT-PCR analysis for virus detection.

    “We are excited to make our highly sensitive RT-PCR test kits available in the United States as we continue to see spikes in COVID diagnoses in multiple areas,” said Gerald Commissiong, Todos Medical’s President & CEO. “We have taken a thoughtful and measured approach to addressing our nation’s COVID-19 testing bottlenecks, including a shortage of equipment, personnel and reagents, and will now begin to work on reducing lengthy turnaround times for results that often leads to questionable accuracy by focusing on our mobile lab initiatives. These initiatives have been making great strides in the last several weeks and will serve as a new distribution channel for our products.“

    “Our goal is to be a one-stop solution for all COVID testing including PCR tests, antigen tests, antibody tests and our proprietary 3C protease rapid test, as Todos begins to play a more prominent role in addressing the global COVID-19 crisis,” Mr. Commissiong continued. “With the full validation of our Todos branded COVID-19 test kits now complete and submissions to FDA ongoing, we are currently validating our proprietary COVID + flu A/B test and intend to submit it to the FDA. Todos is positioning itself as a science-focused leader in the COVID-19 space that will stay at the forefront of the science and medical need in order to provide intelligent solutions that address the key challenges emerging worldwide.”
    Todos Medical Announces Commercial Launch of Todos Branded COVID-19 qPCR Test Kits in the United States
    investor.todosmedical.com
  • D
    David
    Some light reading from Barrons today (TODOS)

    instructions for use (IFU) include use of Todos proprietary ANDis 350 extraction system and extraction reagents that ensure consistency in the RNA extraction and purification process prior to RT-PCR analysis for virus detection.
    'We are excited to make our highly sensitive RT-PCR test kits available in the United States as we continue to see spikes in COVID diagnoses in multiple areas,' said Gerald Commissiong, Todos Medical's President & CEO. 'We have taken a thoughtful and measured approach to addressing our nation's COVID-19 testing bottlenecks, including a shortage of equipment, personnel and reagents, and will now begin to work on reducing lengthy turnaround times for results that often leads to questionable accuracy by focusing on our mobile lab initiatives. These initiatives have been making great strides in the last several weeks and will serve as a new distribution channel for our products.'
    'Our goal is to be a one-stop solution for all COVID testing including PCR tests, antigen tests, antibody tests and our proprietary 3C protease rapid test, as Todos begins to play a more prominent role in addressing the global COVID-19 crisis,' Mr. Commissiong continued. 'With the full validation of our Todos branded COVID-19 test kits now complete and submissions to FDA ongoing, we are currently validating our proprietary COVID + flu A/B test and intend to submit it to the FDA. Todos is positioning itself as a science-focused leader in the COVID-19 space that will stay at the forefront of the science and medical need in order to provide intelligent solutions that address the key challenges emerging worldwide.'
  • n
    noah
    Gerald Said on a reply from a tweet saying he’s going to be addressing the shareholders soon.
    Bullish
  • A
    Anonymous
    Wisconsin!!!!!

    The initial contract is for 8 months. Todos has also been granted a priority right to supply the lab with up to 100,000 COVID PCR tests per day in the event the laboratory sees significant additional testing demand. This customer has entered into an agreement with the State of Wisconsin to supply COVID-19 PCR tests.
    Bullish
  • D
    David
    Don't know if any institutions or mutuals own TODOS shares. If not, then it would leave the majority of shares as being held by LPC and retail buyers. ~ If LPC is trying to manipulate share price by driving it up, just enough, on the open, in hope that traders buy-in; then, they can drive price down by buying their own shares back in small blocks at a lower price. This action would motivate day traders and nervous short-term shareholders to sell in order to keep small gains or reduce losses. What a wicked game!
  • D
    David
    So many posters here seemed determined to bad mouth this stock. Makes one wonder. Me, I like what they are building, and I like that trials are nearing completion. And I am impressed as hell with the 100%/100% selectivity and sensitivity results for their covid tests. That's an attention getter. There's more, of course, but do your own DD. GLTA, whatever your motivations.
  • B
    Brad
    This story came out last night and it was shown again this morning during prime WakeUp air hours. This is huge to see. They are now entering the media spotlight for every household and retail investor to see. https://www.fox6now.com/news/company-developing-5-minute-covid-19-test-partners-with-wisconsin-lab
    Todos Medical's 5-minute COVID-19 test requires a simple sample from your mouth.
    Todos Medical's 5-minute COVID-19 test requires a simple sample from your mouth.
    www.fox6now.com
  • K
    Knowfoolin
    Browsed Todos Medical prospectus Form 1s. Gleaned this:

    August 5, 2020, we sold 3,437,500 ordinary shares to Lincoln Park in an initial purchase under the purchase agreement for a total purchase price of $275,000. We also issued 5,812,500 ordinary shares to Lincoln Park as consideration for its irrevocable commitment to purchase our ordinary shares.
    On August 13, we filed another registration statement on F-1 including a prospectus for the resale of up to an additional 140,529,167 of our ordinary shares by certain investors pursuant to purchase agreements, and for the resale of shares obtained by the exercise of warrants and the conversion of convertible notes by certain of our shareholders (the “Other F-1”).
  • D
    David
    They have so many different forms of covid test kits in their plans, it's not clear to me which specific one today's PR dealt with. Does it have anything to do with the specific company owned saliva one currently in the trial stage?
  • D
    David
    Just building out a bigger future for themselves, globally. Longer term, this is much more than just a covid play. And that future is well along. That's what this morning's PR says to me. GLTA
  • a
    andy1
    Path to Nasdaq

    Todos has been evaluating how best to achieve a national listing on the Nasdaq for some time. With the Company’s financial position steadily improving, we have become very focused on the mechanics to make this transition happen. We have heard from several investors that this listing would be a transformational event for the Company. As such, all of our institutional shareholders who invested between January 2019 and March 2020 believe that the Company’s common stock is sorely undervalued, and as a show of support have agreed to cease diluting the Company’s common stock for approximately one month, at no cost to the Company.
  • D
    David
    I'm seeing the same tricks, in Level III bids: HUGE blocks.
    This tells me LPC, or other client gifted shares are being dumped. ~ Retailers hold tight.